Hyliion is trading 10.1% up at $4.15 as investors continue to respond to its Q1 2026 earnings beat and significant progress on military-related milestones.
- The stock is extending its recent multi-day rebound as the company hits key operational benchmarks.
- Sentiment is further supported by a strong risk-on backdrop across the broader market, with major U.S. indices rising approximately 2%.